Report cover image

Pharmaceutical Glass Packaging Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

Publisher Global Market Insights
Published Jul 07, 2025
Length 344 Pages
SKU # GMI20284296

Description

The Global Pharmaceutical Glass Packaging Market was valued at USD 21.9 billion in 2024 and is estimated to grow at a CAGR of 10.1% to reach USD 56.7 billion by 2034. The growth is driven by the rising adoption of sterile drug packaging, increasing demand for biologics, and stringent regulatory standards for pharmaceutical packaging safety. Pharmaceutical glass packaging plays a crucial role in maintaining drug stability, protecting contents from external contamination, and extending shelf life. The superior inertness, transparency, and barrier properties of glass make it a preferred material for both oral and parenteral drug delivery formats across global pharmaceutical supply chains.

Growing emphasis on contamination-free drug storage, the rise in injectable formulations, and the expanding prevalence of chronic and infectious diseases are bolstering demand for high-quality pharmaceutical glass containers. Regulatory authorities, such as the FDA and EMA, have emphasized the need for packaging materials that ensure minimal interaction between the drug and the container, accelerating the adoption of premium-grade glass containers. Additionally, pharmaceutical companies are investing in automation and smart packaging lines to support scalability and minimize breakage risks during transportation and storage.

The Pharmaceutical Glass Packaging Market is primarily segmented by product type, with vials emerging as the leading segment in 2024, accounting for USD 7.7 billion. Vials are widely used for storing vaccines, biologics, and injectable drugs due to their excellent chemical resistance and capacity to maintain drug potency over extended periods. The surge in global vaccine initiatives and parenteral therapies is fueling vial demand. Manufacturers are introducing lightweight, damage-resistant vials with enhanced thermal shock resistance to meet evolving pharmaceutical requirements.

By material type, Type I (Borosilicate Glass) dominated the market in 2024, contributing USD 7.8 billion in revenue. Borosilicate glass is highly preferred in pharmaceutical applications due to its superior resistance to thermal shock, chemical corrosion, and leaching. It is the material of choice for storing sensitive drugs and biologics, including insulin, oncology treatments, and monoclonal antibodies. As biopharmaceutical innovation accelerates, Type I glass continues to be the gold standard for high-purity drug storage.

In terms of application, oral formulations led the pharmaceutical glass packaging market, generating USD 7.5 billion in 2024. The widespread consumption of tablets, capsules, and liquid suspensions for both prescription and over-the-counter (OTC) medications is driving demand for reliable, child-resistant, and tamper-evident glass packaging solutions. Amber and flint glass bottles, used extensively for syrups and tonics, offer light protection and chemical stability, making them suitable for sensitive APIs.

By end-use, pharmaceutical companies were the major contributors to market demand, accounting for USD 9.1 billion in 2024. The growing pipeline of new drug launches, especially in biologics and generics, is encouraging pharma companies to invest in durable and scalable packaging formats. Strategic collaborations with packaging providers and investments in in-house filling lines are allowing pharmaceutical firms to meet GMP-compliant, high-throughput packaging needs.

North America led the global pharmaceutical glass packaging market in 2024, generating USD 7.7 billion in revenue. The region’s dominance is supported by a strong pharmaceutical manufacturing base, well-established healthcare infrastructure, and ongoing innovation in drug delivery systems. The U.S., home to major pharma players and contract manufacturing organizations, is witnessing robust demand for high-performance glass containers. Regulatory focus on drug safety, coupled with increasing investments in cold-chain packaging and smart serialization technologies, is further fueling regional market expansion.

Key players, such as Schott AG, Gerresheimer AG, Corning Incorporated, Nipro Corporation, and DWK Life Sciences GmbH, are reinforcing their market presence through capacity expansions, product innovation, and strategic partnerships. These companies are focusing on eco-friendly production techniques, enhanced glass durability, and digitization of supply chains to meet the dynamic requirements of pharmaceutical customers globally. Developments such as modular cleanroom glass manufacturing, low-alkali leaching compositions, and hybrid polymer-glass blends are expected to shape the future of pharmaceutical packaging.

Table of Contents

344 Pages
Chapter 1: Methodology
1.1. Research Design
1.1.1. Research approach
1.1.2. Data collection methods
1.1.3. Base estimates and calculations
1.1.4. Base year calculation
1.1.5. Key trends for market estimates
1.2. Forecast model
1.3. Primary research & validation
1.4. Some of the primary sources (but not limited to):
1.4.1. Inputs from primary interviews:
1.5. Data Mining Sources
1.5.1. Secondary Sources
1.5.1.1. Paid Sources
1.5.1.2. Public Sources
1.6. Sources, by region
Chapter 2: Executive Summary
2.1. Industry snapshot
2.2. Business trends
2.3. Product type trends
2.4. Material type trends
2.5. Drug type trends
2.6. Application trends
2.7. End user trends
2.8. Regional trends
Chapter 3: Industry Insights
3.1. Industry snapshot
3.1.1. Raw material supplier
3.1.2. Manufacturers
3.1.3. Distributor
3.1.4. Pharmaceutical companies
3.1.5. End users
3.1.6. Vendor matrix
3.1.7. Profit margin analysis
3.2. Industry impact forces
3.2.1. Growth drivers
3.2.1.1. Rising demand for biologics and injectable drugs
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Stringent regulatory requirements for drug safety
3.2.1.4. Technological advancements in glass manufacturing
3.2.2. Market restraints
3.2.2.1. High production costs
3.2.2.2. Risk of glass breakage and delamination
3.2.2.3. Competition from alternative packaging materials
3.2.3. Market opportunities
3.2.3.1. Growing demand for ready-to-use (RTU) packaging
3.2.3.2. Expansion in emerging markets
3.2.3.3. Innovations in sustainable glass packaging
3.2.4. Market challenges
3.2.4.1. Supply chain disruptions
3.2.4.2. Compliance with evolving regulatory standards
3.2.4.3. Maintaining sterility and product integrity
3.3. Growth potential
3.4. Innovation and sustainability
3.4.1. Technological innovations in glass formulations
3.4.2. Eco-friendly manufacturing processes
3.4.3. Recycling and circular economy initiatives
3.4.4. Carbon footprint reduction strategies
3.5. Raw material analysis
3.5.1. Key raw materials and their sources
3.5.2. Raw material price trends
3.5.3. Raw Material Supply Scenario
3.6. Porter’s Analysis
3.7. PESTEL Analysis
3.8. Future outlook and emerging trends
3.8.1. Smart packaging technologies
3.8.2. Lightweight glass innovations
3.8.3. Integration with drug delivery systems
3.8.4. Customization and personalization trends
3.9. Sustainability measures
3.9.1. Sustainable materials assessment
3.9.2. Carbon footprint analysis
3.9.3. Circular economy implementation
3.9.4. Sustainability certifications and standards
3.9.5. Sustainability ROI analysis
3.10. Price trends
3.10.1. Historical price analysis (2021–2024)
3.10.2. Price trend drivers
3.10.3. Cost structure analysis
3.10.4. Regional price variations
3.10.5. Price forecast (2025-2034)
3.10.6. Global consumer sentiment analysis
3.10.7. Regulatory landscape
3.11. Global regulatory framework
3.12. Regional regulatory variations
3.12.1. North America
3.12.2. Europe
3.12.3. Asia Pacific
3.12.4. Latin America
3.12.5. Middle East and Africa
Chapter 4: Competitive Landscape, 2024
4.1. Competitive Landscape
4.2. Company market share analysis, 2024
4.2.1. Global Market Share by Company
4.2.2. Regional Market Share by Company
4.3. Competitive benchmarking
4.3.1. Product portfolio analysis
4.3.2. Geographical presence
4.3.3. Manufacturing capabilities
4.3.4. R&D investments
4.4. Strategic initiatives analysis
4.4.1. Mergers and acquisitions
4.4.2. Partnerships and collaborations
4.4.3. Product launches and innovations
4.4.4. Expansion initiatives
4.5. Strategic Initiative
4.6. Competitive positioning matrix
4.7. Strategic Outlook Matrix
4.8. SWOT Analysis of Key Players
4.9. Competitive strategies adopted by key players
4.10. Emerging players and their market potential
Chapter 5: Pharmaceutical Glass Packaging Market, By Product Type
5.1. Key Trends
5.2. Vials
5.3. Bottles
5.4. Ampoules
5.5. Cartridges
5.6. Syringes
5.7. Others
Chapter 6: Pharmaceutical Glass Packaging Market, By Material Type
6.1. Key Trends
6.2. Type I (Borosilicate Glass)
6.3. Type II (Treated Soda-Lime Glass)
6.4. Type III (Regular Soda-Lime Glass)
6.5. Type IV (General Purpose Soda-Lime Glass)
6.6. Aluminosilicate Glass
Chapter 7: Pharmaceutical Glass Packaging Market, By Drug Type
7.1. Key Trends
7.2. Generic Drugs
7.3. Biologic Drugs
7.4. OTC Drugs
Chapter 8: Pharmaceutical Glass Packaging Market, By Application
8.1. Key Trends
8.2. Oral Formulations
8.3. Injectable Formulations
8.4. Nasal/Topical Formulations
8.5. Others
Chapter 9: Pharmaceutical Glass Packaging Market, By End User
9.1. Key Trends
9.2. Pharmaceutical Companies
9.3. CMOs (Contract Manufacturing Organizations)
9.4. CPOs (Contract Packaging Organizations)
9.5. Research Laboratories
9.6. Others
Chapter 10: Pharmaceutical Glass Packaging Market, By Region
10.1. Key Trends
10.2. North America
10.3. Europe
10.4. Asia Pacific
10.5. Latin America
10.6. Middle East & Africa (MEA)
Chapter 11: Company Profiles
11.1. Arab Pharmaceutical Glass Co.
11.1.1. Financial Data
11.1.2. Product Landscape
11.1.3. SWOT Analysis
11.2. Ardagh Group S.A
11.2.1. Financial Data
11.2.2. Product Landscape
11.2.3. SWOT Analysis
11.3. Beatson Clark
11.3.1. Financial Data
11.3.2. Product Landscape
11.3.3. SWOT Analysis
11.4. Bormioli Pharma (Gerresheimer AG)
11.4.1. Financial Data
11.4.2. Product Landscape
11.4.3. Strategic Outlook
11.4.4. SWOT Analysis
11.5. Corning Incorporated
11.5.1. Financial Data
11.5.2. Product Landscape
11.5.3. Strategic Outlook
11.5.4. SWOT Analysis
11.6. DWK Life Sciences
11.6.1. Financial Data
11.6.2. Product Landscape
11.6.3. Strategic Outlook
11.6.4. SWOT Analysis
11.7. Gerresheimer AG
11.7.1. Financial Data
11.7.2. Product Landscape
11.7.3. Strategic Outlook
11.7.4. SWOT Analysis
11.8. Glassco
11.8.1. Financial Data
11.8.2. Product Landscape
11.8.3. SWOT Analysis
11.9. Nipro Corporation
11.9.1. Financial Data
11.9.2. Product Landscape
11.9.3. Strategic Outlook
11.9.4. SWOT Analysis
11.10. PGP Glass Private Limited (Piramal Glass)
11.10.1. Financial Data
11.10.2. Product Landscape
11.10.3. SWOT Analysis
11.11. Schott AG (Schott Pharma)
11.11.1. Financial Data
11.11.2. Product Landscape
11.11.3. Strategic Outlook
11.11.4. SWOT Analysis
11.12. SGD S.A.
11.12.1. Financial Data
11.12.2. Product Landscape
11.12.3. Strategic Outlook
11.12.4. SWOT Analysis
11.13. Shandong Medicinal Glass Co., Ltd.
11.13.1. Financial Data
11.13.2. Product Landscape
11.13.3. SWOT Analysis
11.14. Stevanato Group S.p.A.
11.14.1. Financial Data
11.14.2. Product Landscape
11.14.3. Strategic Outlook
11.14.4. SWOT Analysis
11.15. Stoelzle Oberglas GmbH
11.15.1. Financial Data
11.15.2. Product Landscape
11.15.3. SWOT Analysis
11.16. United Glass Company (UGC)
11.16.1. Financial Data
11.16.2. Product Landscape
11.16.3. SWOT Analysis
11.17. West Pharmaceutical Services, Inc.
11.17.1. Financial Data
11.17.2. Product Landscape
11.17.3. Strategic Outlook
11.17.4. SWOT Analysis
Chapter 12: Company Profiles
12.1. Market Definitions

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us